
FDA Announces Groundbreaking Move to Phase Out Animal Testing Requirements-and EPA May Follow Suit
In a significant development aligning closely with NAVS’ mission, the U.S. Food and Drug Administration (FDA) recently announced a landmark plan to phase out animal testing requirements for monoclonal antibodies and other drugs.